Oxford Handbook of Oncology, 5th Edition

Review from previous edition Written by experts in the field to ensure that it is grounded in real life clinical practice, this Handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding. * Anticancer Research *

Authors

Miranda Payne is a Consultant in Medical Oncology at the Oxford University Hospitals NHS Foundation Trust. Her clinical practice involves routine recruitment to international, academic, industry-sponsored, and observational clinical trials, which is reflected in her publication record. She has a particular interest in the consequences of immunotherapy and the systemic treatment of melanoma. She has served as an editor for the Oxford Handbook of Oncology for over 20 years.

Robert Owens is a Consultant Clinical Oncologist in Oxford, where he also completed his oncology training. He specialises in treating GI cancers and has a specific interest in focused targeted radiotherapy (SABR), especially in the upper GI setting.

Gareth Morris Stiff is a surgical oncologist with 32 years of postgraduate experience, holding specific expertise in hepato-pancreato-biliary (HPB) cancers, and is a Pharma key opinion leader in exocrine pancreatic insufficiency. He has an extensive research portfolio and is widely published in peer-reviewed journals. He has held numerous leadership roles, directing teams and committees within clinical and research arenas up to a national level. He has departed clinical practice to develop anti-cancer therapies with a portfolio including antibodies, small molecules, Ayurvedic-western hybrids, and phytomedicines. He is currently the Global Chief Medical Officer for Equilibrium Labs, developing phytomedicines to aid metabolism dysfunction-associated fatty liver disease and cancer chemotherapy-related adverse events.

Victoria Woodcock is a Consultant in Medical Oncology specialising in the treatment of colorectal cancer. She completed her oncology training in Oxford and undertook a DPhil in Oncology at the University of Oxford, studying immune responses to checkpoint inhibitor treatment in melanoma. Her academic interests include understanding and augmenting immune responses against cancer through conducting clinical trials of novel immunotherapy treatments and translational research.

Dr. Rebecca Shakir is a Clinical Oncology Consultant at the Churchill Hospital in Oxford and a post-doctoral academic visitor at Oxford Population Health. Alongside treating patients with head and neck and skin cancer, she specialises in the management of patients with the long-term side-effects of cancer treatment. Her research focuses on determining the benefits and risks of radiotherapy and shared decision-making. In addition to her clinical work, Rebecca is the Sherrington Lecturer at Magdalen College, Oxford, and a member of the Specialty Training and Professional Standards Boards at the Royal College of Radiologists.

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.